Back to Atlas
APotentially durableResearch-only / high verification need
CMP-0008
Research tool
A-1155463
Senolytic / BCL-xL
Selective senescent-cell apoptosis in susceptible cell types
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- Selective BCL-xL inhibition
- Primary market use
- Senolytic research
Pharmacology
- Molecular weight (Da)
- 669.8
- Oral bioavailability
- Preclinical; oral human data not established
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical
- Clinical status
- Research tool
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
BCL-xL probe with preclinical senolytic evidence; not consumer-ready